Dextech Medical AB (XSAT:DEX)

Dextech Medical AB Statistics

Total Valuation

XSAT:DEX has a market cap or net worth of SEK 162.68 million. The enterprise value is 147.97 million.

Market Cap	162.68M
Enterprise Value	147.97M

Important Dates

The next estimated earnings date is Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

XSAT:DEX has 18.49 million shares outstanding. The number of shares has decreased by -1.79% in one year.

Current Share Class	18.49M
Shares Outstanding	18.49M
Shares Change (YoY)	-1.79%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	53.20%
Owned by Institutions (%)	n/a
Float	7.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	50.47
PB Ratio	6.57
P/TBV Ratio	6.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.54
EV / Sales	45.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 45.07

Current Ratio	45.07
Quick Ratio	43.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.82% and return on invested capital (ROIC) is -12.23%.

Return on Equity (ROE)	-17.82%
Return on Assets (ROA)	-11.94%
Return on Invested Capital (ROIC)	-12.23%
Return on Capital Employed (ROCE)	-21.48%
Revenue Per Employee	3.22M
Profits Per Employee	-4.84M
Employee Count	1
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +101.84% in the last 52 weeks. The beta is 1.32, so XSAT:DEX's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	+101.84%
50-Day Moving Average	8.32
200-Day Moving Average	5.77
Relative Strength Index (RSI)	49.11
Average Volume (20 Days)	9,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:DEX had revenue of SEK 3.22 million and -4.84 million in losses. Loss per share was -0.26.

Revenue	3.22M
Gross Profit	3.22M
Operating Income	-5.32M
Pretax Income	-4.84M
Net Income	-4.84M
EBITDA	-5.17M
EBIT	-5.32M
Loss Per Share	-0.26

Balance Sheet

The company has 14.71 million in cash and n/a in debt, giving a net cash position of 14.71 million or 0.80 per share.

Cash & Cash Equivalents	14.71M
Total Debt	n/a
Net Cash	14.71M
Net Cash Per Share	0.80
Equity (Book Value)	24.76M
Book Value Per Share	1.34
Working Capital	14.85M

Cash Flow

Operating Cash Flow	-1.11M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -165.01% and -150.32%.

Gross Margin	100.00%
Operating Margin	-165.01%
Pretax Margin	-150.32%
Profit Margin	-150.32%
EBITDA Margin	-160.42%
EBIT Margin	-165.01%
FCF Margin	n/a

Dividends & Yields

XSAT:DEX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.79%
Shareholder Yield	n/a
Earnings Yield	-2.98%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:DEX has an Altman Z-Score of 144.28 and a Piotroski F-Score of 2.

Altman Z-Score	144.28
Piotroski F-Score	2